
SOX10 Role in WT BRAF Melanoma
Career Development Award – Claudia Capparelli, PhD
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Career Development Award – Claudia Capparelli, PhD
Description: The goal of this research is to target KDM5s family proteins to enhance the response to immune checkpoint inhibition in melanoma. The recently developed immune...
There has been great progress in increasing the treatment options for patients who have the skin cancer melanoma in the past decade. However, the melanoma will mo...
Mucosal melanoma presents a significant challenge for oncologists. Compared to cutaneous melanoma, mucosal melanoma has a far lower survival rate and is more difficult to t...
The cancer genomics field has focused on how mutations in the genome change proteins to cause cells to progress into metastatic cancers. However, new molecular profiling te...
Uveal melanoma is an aggressive cancer of the eye. There is no cure for metastatic disease, and therefore it is always fatal. Predictive tests can identify patients with ag...
A type of cancer found in the colored part the eye is called uveal melanoma. This particular type of cancer can often be treated successfully with surgery and radiation. Ho...
Immunotherapies, such as CTLA-4 or PD-1 inhibitors, have revolutionized the treatment of metastatic melanoma patients. However, a key challenge to optimize the opportunity ...
Uveal melanoma is a type of melanoma that occurs in the eye as opposed to the most common presentations of melanoma, which occur on the skin. A diagnosis of uveal ...
Description: The major cause of death in uveal melanoma patients is the spread or metastasis of the cancer to other vital organs such as the liver. Although most ...
Career Development Award – Inna Fedorenko, PhD
Career Development Award – Poulikos Poulikakos, PhD
Oct 16, 2025 ET
Oct 30, 2025 ET